Astria Therapeutics to Present at Upcoming Western Society of Allergy, Asthma & Immunology Annual Scientific Session
Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced that it will present quality ...
Le Lézard16h
Nuvation Bio Announces Expanded Access Program in the U.S. for Taletrectinib in Advanced ROS1-positive Non-Small Cell Lung Cancer
Nuvation Bio Inc. , a global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today announced it has initiated an Expanded Access Program (EAP) for taletrectinib in the ...
Le Lézard16h
Biocodex Microbiota Foundation Announces Open Call for Project for $50,000 2025 USA Microbiome Research Grant
The Biocodex Microbiota Foundation, an independent organization founded by Biocodex, has opened applications for its 2025 USA research grant. Now in its 9th year, the $50,000 grant, juried by a panel ...